Text Correction
There was an error in the original publication [1]. A typo in the twelfth sentence of the first paragraph of Section 2.3, “Cefazolin vs. ASPs”, was noted by the authors. It should read “p = 0.034” instead of “p = 0.34”.
The authors state that the scientific conclusions are unaffected. This correction was approved by the Academic Editor. The original publication has also been updated.
Footnotes
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.
Reference
- 1.Adema J.L., Ahiskali A., Fida M., Mediwala Hornback K., Stevens R.W., Rivera C.G. Heartbreaking Decisions: The Dogma and Uncertainties of Antimicrobial Therapy in Infective Endocarditis. Pathogens. 2023;12:703. doi: 10.3390/pathogens12050703. [DOI] [PMC free article] [PubMed] [Google Scholar]